,file,ref_number,ref_text,doi,doi_url
0,experiments/glioblastoma_survival/ai_messages/high_complexity--generated_PTEN_MGMT_medium_methylated,[1],"Song MS, Salmena L, Pandolfi PP. 2012. Nature Reviews Molecular Cell Biology. The functions and regulation of the PTEN tumour suppressor.",10.1038/nrm3330,https://doi.org/10.1038/nrm3330
1,experiments/glioblastoma_survival/ai_messages/high_complexity--generated_PTEN_MGMT_medium_methylated,[2],"Hegi ME, Diserens AC, Gorlia T, et al. 2005. New England Journal of Medicine. MGMT gene silencing and benefit from temozolomide in glioblastoma.",10.1056/nejmoa043331,https://doi.org/10.1056/nejmoa043331
2,experiments/glioblastoma_survival/ai_messages/high_complexity--generated_PTEN_MGMT_medium_methylated,[3],Cancer Genome Atlas Research Network. 2008. Nature. Comprehensive genomic characterization defines human glioblastoma genes and core pathways.,10.1038/nature07385,https://doi.org/10.1038/nature07385
3,experiments/glioblastoma_survival/ai_messages/high_complexity--generated_PTEN_MGMT_medium_methylated,[4],"Ostrom QT, Gittleman H, Liao P, et al. 2014. Neuro-Oncology. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011.",10.1093/neuonc/nou223,https://doi.org/10.1093/neuonc/nou223
4,experiments/glioblastoma_survival/ai_messages/high_complexity--generated_PTEN_MGMT_medium_methylated,[5],"Stupp R, Mason WP, van den Bent MJ, et al. 2005. New England Journal of Medicine. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.",10.1097/01.cot.0000289242.47980.f9,https://doi.org/10.1097/01.cot.0000289242.47980.f9
5,experiments/glioblastoma_survival/ai_messages/high_complexity--generated_PTEN_MGMT_medium_methylated,[6],"Wen PY, Reardon DA. 2016. Journal of Clinical Oncology. Neuro-oncology in 2015: Progress in glioma diagnosis, classification and treatment.",10.1038/nrneurol.2015.242,https://doi.org/10.1038/nrneurol.2015.242
